"Mirikizumab Effective in Crohn’s Induction" - Alex Young
Alfred Burger, MD, associate professor of medicine, hospital medicine, and medical education at the Icahn School of Medicine at Mount Sinai discusses the top clinical guidelines every hospitalist needs to know. When explaining C diff, Dr. Burger says “We really need to understand that metronidazole is no longer a choice as a first-line agent for standard C diff. We should be moving to vancomycin or some of the newer agents—fidaxomicin is the one they recommend—for a ten day course for treatment. The other changes have been around how we should treat the first, second, and third recurrence.”
— Alfred P. Burger, MD, Associate Professor, Medicine, Hospital Medicine, Medical Education, Icahn School of Medicine at Mount Sinai
